Two experiments were conducted to determine the effect of tamoxifen (T
AM) in mouse endometrium in comparison with that of 17 beta-estradiol
(E-2), In a medium-term assay, TAM as well as E-2 treatment semi-dose-
dependently increased the levels of fos/jun mRNA and their oncoprotein
s (Fos/Jun), The long-term effect of TAM on mouse endometrial carcinog
enesis was also examined in the following model. A total of 150 female
ICR mice, 12-13 weeks of age, were used. Of these, 125 mice received
an injection of N-methyl-N-nitrosourea (MNU) solution (1 mg/100 g body
weight) into their left uterine tube and saline into the right. One w
eek later, they were divided into four groups: groups 1 (35 mice) and
2 (30 mice) were given 25 ppm and 5 ppm E-2-containing diet, respectiv
ely, while group 3 (30 mice) was fed 5 ppm TAM-containing diet. Group
5 (30 mice) was fed basal diet alone. The remaining 25 mice (group 4)
received 5 ppm TAM-containing diet alone. At the termination of the ex
periment (30 weeks), endometrial carcinomas were confirmed to be prese
nt in the groups exposed to MNU. TAM increased the incidence of preneo
plastic lesions of the endometrium, while E(2 )enhanced the occurrence
of the carcinoma. No carcinomas were found in the group given TAM alo
ne, In the ovaries, corpora lutea were lacking in most of the mice exp
osed to TAM, suggesting that the animals were not cycling. Such findin
gs indicate that TAM has an enhancing effect on endometrial carcinogen
esis in mice, probably via a mechanism involving overexpression of Fos
/Jun proteins.